122 related articles for article (PubMed ID: 37542520)
21. Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study.
Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Peltonen J; Peltonen S
Orphanet J Rare Dis; 2018 Jan; 13(1):5. PubMed ID: 29335026
[TBL] [Abstract][Full Text] [Related]
22. The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from Finland.
Johansson E; Kallionpää RA; Böckerman P; Peltonen S; Peltonen J
Genet Med; 2022 Apr; 24(4):870-879. PubMed ID: 34955382
[TBL] [Abstract][Full Text] [Related]
23. Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.
Rosenberg AGW; Mochèl K; Hähner LM; Ruules L; Davidse K; Bos-Roubos AG; van Dijk SA; Zillikens MC; Taal W; van der Lely AJ; de Graaff LCG
Front Endocrinol (Lausanne); 2023; 14():1119159. PubMed ID: 38560379
[TBL] [Abstract][Full Text] [Related]
24. Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1.
Bhatia S; Chen Y; Wong FL; Hageman L; Smith K; Korf B; Cannon A; Leidy DJ; Paz A; Andress JE; Friedman GK; Metrock K; Neglia JP; Arnold M; Turcotte LM; de Blank P; Leisenring W; Armstrong GT; Robison LL; Clapp DW; Shannon K; Nakamura JL; Fisher MJ
J Clin Oncol; 2019 Nov; 37(32):3050-3058. PubMed ID: 31532722
[TBL] [Abstract][Full Text] [Related]
25. Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects.
Zinnamosca L; Petramala L; Cotesta D; Marinelli C; Schina M; Cianci R; Giustini S; Sciomer S; Anastasi E; Calvieri S; De Toma G; Letizia C
Arch Dermatol Res; 2011 Jul; 303(5):317-25. PubMed ID: 21042801
[TBL] [Abstract][Full Text] [Related]
26. Neurofibromatosis type 1 and pregnancy complications: a population-based study.
Terry AR; Barker FG; Leffert L; Bateman BT; Souter I; Plotkin SR
Am J Obstet Gynecol; 2013 Jul; 209(1):46.e1-8. PubMed ID: 23535241
[TBL] [Abstract][Full Text] [Related]
27. The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study.
Al-Mashhadi ZK; Viggers R; Fuglsang-Nielsen R; Vestergaard P; Gregersen S; Starup-Linde J
Front Endocrinol (Lausanne); 2022; 13():882998. PubMed ID: 36299454
[TBL] [Abstract][Full Text] [Related]
28. Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage.
Kurtelius A; Kallionpää RA; Huttunen J; Huttunen TJ; Helin K; Koivisto T; Frösen J; von Und Zu Fraunberg M; Peltonen S; Peltonen J; Jääskeläinen JE; Lindgren AE
PLoS One; 2017; 12(6):e0178711. PubMed ID: 28575128
[TBL] [Abstract][Full Text] [Related]
29. Association of pheochromocytoma and ganglioneuroma: unusual finding in neurofibromatosis type 1.
Mezitis SG; Geller M; Bocchieri E; Del Pizzo J; Merlin S
Endocr Pract; 2007 Oct; 13(6):647-51. PubMed ID: 17954422
[TBL] [Abstract][Full Text] [Related]
30. Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1.
Moramarco J; El Ghorayeb N; Dumas N; Nolet S; Boulanger L; Burnichon N; Lacroix A; Elhaffaf Z; Gimenez Roqueplo AP; Hamet P; Bourdeau I
Clin Endocrinol (Oxf); 2017 Mar; 86(3):332-339. PubMed ID: 27787920
[TBL] [Abstract][Full Text] [Related]
31. A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age.
Heervä E; Koffert A; Jokinen E; Kuorilehto T; Peltonen S; Aro HT; Peltonen J
J Bone Miner Res; 2012 Nov; 27(11):2333-7. PubMed ID: 22692994
[TBL] [Abstract][Full Text] [Related]
32. Pheochromocytoma in Neurofibromatosis Type 1: When Should it Be Suspected?
Shinall MC; Solórzano CC
Endocr Pract; 2014 Aug; 20(8):792-6. PubMed ID: 24518181
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis I and multiple sclerosis.
Bergqvist C; Hemery F; Ferkal S; Wolkenstein P
Orphanet J Rare Dis; 2020 Jul; 15(1):186. PubMed ID: 32664938
[TBL] [Abstract][Full Text] [Related]
34. A rare disease and education: Neurofibromatosis type 1 decreases educational attainment.
Johansson E; Kallionpää RA; Böckerman P; Peltonen J; Peltonen S
Clin Genet; 2021 Apr; 99(4):529-539. PubMed ID: 33368180
[TBL] [Abstract][Full Text] [Related]
35. Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study.
de Blank P; Li N; Fisher MJ; Ullrich NJ; Bhatia S; Yasui Y; Sklar CA; Leisenring W; Howell R; Oeffinger K; Hardy K; Okcu MF; Gibson TM; Robison LL; Armstrong GT; Krull KR
Genet Med; 2020 Nov; 22(11):1794-1802. PubMed ID: 32572180
[TBL] [Abstract][Full Text] [Related]
36. Birth Characteristics Among Children Diagnosed with Neurofibromatosis Type 1 and Tuberous Sclerosis.
Tettamanti G; Mogensen H; Kampitsi CE; Nordgren A; Feychting M
J Pediatr; 2021 Dec; 239():200-205.e2. PubMed ID: 34390698
[TBL] [Abstract][Full Text] [Related]
37. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
38. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
39. A Nationwide Study Characterizing the Risk and Outcome Profiles of Multilevel Fusion Procedures in Neuromuscular Scoliosis Patients with Neurofibromatosis Type 1.
Price G; Martini ML; Caridi JM; Lau D; Oermann EK; Neifert SN
World Neurosurg; 2023 Mar; 171():e620-e630. PubMed ID: 36586581
[TBL] [Abstract][Full Text] [Related]
40. Giant phaeochromocytoma presenting with an acute stroke: reappraising phaeochromocytoma surveillance for the neurofibromatosis type 1 phakomatosis.
Lee Y; Tan LYR; Ho YH; Leow MKS
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29102976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
